tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Andrew Baum, 65 are a BUY (53.28%), 53 are a HOLD (43.44%), 4 are a SELL (3.28%).
Analyst Andrew Baum, currently employed at CITI, carries an average stock price target met ratio of 81.26% that have a potential upside of 31.1% achieved within 595 days.
Andrew Baum’s has documented 240 price targets and ratings displayed on 12 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on BMY, Bristol-Myers Squibb Company at 27-Jan-2026.
Analyst best performing recommendations are on LLY (ELI LILLY AND COMPANY).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 7/26/2023. The price target of $525 was fulfilled within 19 days with a profit of $81.61 (18.41%) receiving and performance score of 9.69.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Sep-2026
$315
$52.18 (19.85%)
$265
25 days ago
(10-Sep-2026)
6/7 (85.71%)
$60 (23.53%)
115
Buy Since 12-Sep-2025
$303
$40.18 (15.29%)
$298
1 months 15 days ago
(20-Aug-2026)
2/11 (18.18%)
$41.17 (15.72%)
35
Buy Since 09-Dec-2021
$300
$37.18 (14.15%)
$295
1 months 18 days ago
(17-Aug-2026)
14/16 (87.5%)
$49.67 (19.84%)
506
Hold Since 13-Aug-2026
$300
$37.18 (14.15%)
1 months 22 days ago
(13-Aug-2026)
1/2 (50%)
$49.18 (19.61%)
115
Buy Since 23-Jan-2023
$260
$-2.82 (-1.07%)
$235
1 months 25 days ago
(10-Aug-2026)
9/9 (100%)
$12.03 (4.85%)
133
What Year was the first public recommendation made by Andrew Baum?
